GLTO
NASDAQ
Galecto, Inc. - Common Stock
Healthcare
· Biotechnology
$25.09
▲ +$0.01
(+0.04%)
Vol 230K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$36.7M
ROE
-130.7%
D/E
0.00
Beta
1.45
52W
$2–$38
Price Chart
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -108.0% | -108.0% | -108.0% | -108.0% | -130.7% | -130.7% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 4.96 | 4.96 | 4.96 | 4.96 | 3.73 | 3.73 |
Key Ratios
ROA (TTM)
-111.3%
P/B
0.4
EPS (TTM)
$-12.01
CF/Share
$-1.74
52W High
$38.33
52W Low
$2.01
$2.01
52-Week Range
$38.33
How does GLTO compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
GLTO valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.4
▼
84%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
GLTO profitability vs Biotechnology peers
ROE
-130.7%
▼
94%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-111.3%
▼
138%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
GLTO financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
3.7
▼
16%
below
peers
(4.4)
vs Peers
vs Industry
Below avg
Beta
1.5
▲
49%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
GLTO fundamentals radar
GLTO
Peer median
Industry
GLTO profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
GLTO vs peers: key metrics
Latest News
No related news yet